Evidence map›Paper›PMID 37074433›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2023

Epidemiology of Enteroaggregative, Enteropathogenic, and Shiga Toxin-Producing Escherichia coli Among Children Aged <5 Years in 3 Countries in Africa, 2015-2018: Vaccine Impact on Diarrhea in Africa (VIDA) Study.

John B Ochieng, Helen Powell, Ciara E Sugerman, Richard Omore, Billy Ogwel, Jane Juma, Alex O Awuor, Samba O Sow, Doh Sanogo, Uma Onwuchekwa and 22 more

Open access · hybridAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Detection ofInfection and drug resistance · 2025
    Article
  8. EnteroaggregativeFrontiers in microbiology · 2025
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 9 institutions in 5 countries.

John B OchiengKenya Medical Research Institute, Center for Global Health Research, Kisumu, Kenya.
Helen PowellCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Ciara E SugermanDivision of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Richard OmoreKenya Medical Research Institute, Center for Global Health Research, Kisumu, Kenya.
Billy OgwelKenya Medical Research Institute, Center for Global Health Research, Kisumu, Kenya.
Jane JumaKenya Medical Research Institute, Center for Global Health Research, Kisumu, Kenya.
Alex O AwuorKenya Medical Research Institute, Center for Global Health Research, Kisumu, Kenya.
Samba O SowCentre pour le Développement des Vaccins du Mali, Bamako, Mali.
Doh SanogoCentre pour le Développement des Vaccins du Mali, Bamako, Mali.
Uma OnwuchekwaCentre pour le Développement des Vaccins du Mali, Bamako, Mali.
Adama Mamby KeitaCentre pour le Développement des Vaccins du Mali, Bamako, Mali.
Awa TraoréCentre pour le Développement des Vaccins du Mali, Bamako, Mali.
Henry BadjiMedical Research Council Unit, The Gambia at the London School of Hygiene & Tropical Medicine, Banjul, The Gambia.
M Jahangir HossainMedical Research Council Unit, The Gambia at the London School of Hygiene & Tropical Medicine, Banjul, The Gambia.
Joquina Chiquita M JonesMedical Research Council Unit, The Gambia at the London School of Hygiene & Tropical Medicine, Banjul, The Gambia.
Irene N KasumbaCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Dilruba NasrinCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Anna RooseCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Yuanyuan LiangCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Leslie P JamkaCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Martin AntonioMedical Research Council Unit, The Gambia at the London School of Hygiene & Tropical Medicine, Banjul, The Gambia.
James A Platts-MillsDivision of Infectious Diseases and International Health, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA.
Jie LiuDivision of Infectious Diseases and International Health, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA.
Eric R HouptDivision of Infectious Diseases and International Health, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA.
Eric D MintzDivision of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Elizabeth HunspergerDivision of Global Health Protection, Centers for Disease Control and Prevention, Nairobi, Kenya.
Clayton O OnyangoDivision of Global Health Protection, Centers for Disease Control and Prevention, Nairobi, Kenya.
Nancy StrockbineDivision of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Marc-Alain WiddowsonDivision of Global Health Protection, Centers for Disease Control and Prevention, Nairobi, Kenya.
Jennifer R VeraniDivision of Global Health Protection, Centers for Disease Control and Prevention, Nairobi, Kenya.
Sharon M TennantCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Karen L KotloffCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
University of Maryland, Baltimore · USCentre Pour le Développement des Vaccins-Mali · MLKenya Medical Research Institute · KECenters for Disease Control and Prevention · KEMRC Unit the Gambia · GMCenters for Disease Control and Prevention · USUniversity of Virginia · USQingdao University · CNWaterborne Environmental (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo address knowledge gaps regarding diarrheagenic Escherichia coli (DEC) in Africa, we assessed the clinical and epidemiological features of enteroaggregative E. coli (EAEC), enteropathogenic E. coli (EPEC), and Shiga toxin-producing E. coli (STEC) positive children with moderate-to-severe diarrhea (MSD) in Mali, The Gambia, and Kenya.

methodsBetween May 2015 and July 2018, children aged 0-59 months with medically attended MSD and matched controls without diarrhea were enrolled. Stools were tested conventionally using culture and multiplex polymerase chain reaction (PCR), and by quantitative PCR (qPCR). We assessed DEC detection by site, age, clinical characteristics, and enteric coinfection.

resultsAmong 4840 children with MSD and 6213 matched controls enrolled, 4836 cases and 1 control per case were tested using qPCR. Of the DEC detected with TAC, 61.1% were EAEC, 25.3% atypical EPEC (aEPEC), 22.4% typical EPEC (tEPEC), and 7.2% STEC. Detection was higher in controls than in MSD cases for EAEC (63.9% vs 58.3%, P < .01), aEPEC (27.3% vs 23.3%, P < .01), and STEC (9.3% vs 5.1%, P < .01). EAEC and tEPEC were more frequent in children aged <23 months, aEPEC was similar across age strata, and STEC increased with age. No association between nutritional status at follow-up and DEC pathotypes was found. DEC coinfection with Shigella/enteroinvasive E. coli was more common among cases (P < .01).

conclusionsNo significant association was detected between EAEC, tEPEC, aEPEC, or STEC and MSD using either conventional assay or TAC. Genomic analysis may provide a better definition of the virulence factors associated with diarrheal disease.

Indexed as

CoinfectionEnteropathogenic Escherichia coliEscherichia coli InfectionsShiga-Toxigenic Escherichia coliChildDiarrheaHumansKenyadiarrheagenic E. coliEAECEPECpediatric diarrheaSTEC

Identifiers

PMID37074433
PMCPMC10116530
OpenAlexW4366352795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.